Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
- PMID: 32659385
- PMCID: PMC7348600
- DOI: 10.1016/j.cmi.2020.07.010
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
References
-
- Schauwvlieghe A., Rijnders B.J.A., Philips N., Verwijs R., Vanderbeke L., Van Tienen C., Dutch-Belgian Mycosis study group Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–792. - PubMed
-
- Verweij P.E., Rijnders B.J.A., Bruggemann R.J.M., Azoulay E., Bassetti M., Blot S. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020:1–12. doi: 10.1007/s00134-020-06091-6. Online ahead of print. - DOI - PMC - PubMed
-
- Donnelly J.P., Chen S.C., Kauffman C.A., Steinbach W.J., Baddley J.W., Verweij P.E. Revision and update of the consensus definitions of invasive fungal disease from the European organization for Research and treatment of cancer and the Mycoses study Group education and Research consortium. Clin Infect Dis. 2019:ciz1008. doi: 10.1093/cid/ciz1008. Online ahead of print. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
